Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End
30 sept. 2022 09h00 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...